We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Mpox, a zoonotic disease, has emerged as a significant international public health concern due to an increase in the number of cases diagnosed in non-endemic countries. To support public health response efforts to interrupt Mpox transmission in the community, this study aims to identify epidemiological and clinical aspects of Mpox in Jakarta, Indonesia.
Methods
The study collected Mpox data from the Provincial Health Department in Jakarta, Indonesia, from October 2023 to February 2024. This included the symptom characteristics and demographics of polymerase chain reaction (PCR)-confirmed and PCR-negative Mpox cases, which were then compared using the χ2 test.
Results
Of the PCR-confirmed total of 58 Mpox cases, most were males (96.6%, 56/58). Of these, 67.2% (39/58) reported recent sexual activity within the 21 days prior to the disease onset date, with 41.4% (24/58) reporting only 1 sexual partner during that period. Among PCR-confirmed Mpox cases, common symptoms included fever (81.1%, 47/58), rash (63.8%, 37/58), and lesions (93.1%, 54/58).
Conclusions
The predominance of male Mpox cases indicates transmission within men who have sex with men (MSM) networks, while higher prevalence among individuals with HIV or syphilis is due to shared behaviors, highlighting the need for surveillance, contact tracing, and targeted public health interventions.
Positive, negative and disorganised psychotic symptom dimensions are associated with clinical and developmental variables, but differing definitions complicate interpretation. Additionally, some variables have had little investigation.
Aims
To investigate associations of psychotic symptom dimensions with clinical and developmental variables, and familial aggregation of symptom dimensions, in multiple samples employing the same definitions.
Method
We investigated associations between lifetime symptom dimensions and clinical and developmental variables in two twin and two general psychosis samples. Dimension symptom scores and most other variables were from the Operational Criteria Checklist. We used logistic regression in generalised linear mixed models for combined sample analysis (n = 875 probands). We also investigated correlations of dimensions within monozygotic (MZ) twin pairs concordant for psychosis (n = 96 pairs).
Results
Higher symptom scores on all three dimensions were associated with poor premorbid social adjustment, never marrying/cohabiting and earlier age at onset, and with a chronic course, most strongly for the negative dimension. The positive dimension was also associated with Black and minority ethnicity and lifetime cannabis use; the negative dimension with male gender; and the disorganised dimension with gradual onset, lower premorbid IQ and substantial within twin-pair correlation. In secondary analysis, disorganised symptoms in MZ twin probands were associated with lower premorbid IQ in their co-twins.
Conclusions
These results confirm associations that dimensions share in common and strengthen the evidence for distinct associations of co-occurring positive symptoms with ethnic minority status, negative symptoms with male gender and disorganised symptoms with substantial familial influences, which may overlap with influences on premorbid IQ.
Clinicians often rely on caregiver proxy symptom reports to treat cancer-related symptoms in children. Research has described disagreement between children’s and caregivers’ symptom reports. Factors influencing the level of agreement is an understudied area. Thus, this study aimed to examine potential factors contributing to the level of agreement between symptom reports provided by children and their caregivers.
Methods
Sixteen child–caregiver dyads participated separately in semi-structured interviews after completing a brief symptom measure independently using an electronic device. Child and caregiver quantitative symptom responses were reviewed in real-time and incorporated into the semi-structured interview. Sample characteristics and the level of agreement between symptom reports were calculated using descriptive statistics. Transcribed participant interviews were analyzed using content analysis.
Results
Nearly half of child–caregiver dyads exhibited a moderate (37.5%, n = 6) or low (18.75%, n = 3) level of agreement on the abbreviated symptom measure. Qualitative analysis identified 5 themes: recognizing symptoms, experiencing symptoms, communicating symptoms, re-assessing and treating symptoms, and influencing individual and relationship factors. Influencing individual, including a child’s tendencies or personality traits, and relationship factors intersected the other themes, partially explained their symptom perceptions, and served to facilitate or hinder symptom communication.
Significance of Results
Symptom communication is an important part of the symptom cycle, comprised of symptom recognition, experience, and management. Individual and relational factors may influence discrepancies in symptom perceptions between the child and caregiver. Clinicians and researchers should consider developing interventions to enhance symptom communication and promote collaboration between children and their caregivers to address symptom suffering during cancer treatment.
Compassion is essential in palliative care; however, there is a lack of evidence of the association between this construct and patients’ dignity-related distress. The present study aimed to investigate the association between end-of-life cancer patients’ sense of dignity, the level of compassion of the healthcare professionals (HCPs) noticed and perceived by the patients, and levels of compassion that HCPs felt they had toward patients, investigating through specific attitudes and behaviors. Furthermore, the relationship between compassion and patients’ physical and psychological symptoms, such as levels of anxiety and depression, was also investigated.
Methods
The study was cross-sectional. The sample consisted of 105 end-of-life cancer patients and 40 HCPs. Patients had a Karnofsky Performance Status of 50 or lower and a life expectancy of less than 4 months. For each patient, sociodemographic data were collected, and a set of rating scales assessing compassion, dignity as well as physical and psychological symptoms were administered.
Results
The results showed significant negative associations between patients’ perception of compassion and dignity-related distress as well as significant negative associations between patients’ perception of compassion and patients’ symptoms.
Significance of results
Compassion seems to be involved in diminishing dignity-related distress and alleviating physical and psychological symptoms. Other studies are needed to understand whether patients’ symptoms or whether specific HCPs’ conditions influence compassion. Exploring compassion and at the end-of-life could encourage a dignity-conserving care.
Edited by
Allan Young, Institute of Psychiatry, King's College London,Marsal Sanches, Baylor College of Medicine, Texas,Jair C. Soares, McGovern Medical School, The University of Texas,Mario Juruena, King's College London
In his book General Psychopathology, first published in 1913, Jaspers presented a methodological framework for exploring the phenomenology of symptoms of psychiatric disorders as well as relating experimental psychology and nosology to phenomenology. This chapter briefly introduces the phenomenological approach to symptoms and how this has influenced symptom- as opposed to diagnostic criterion-based assessment instruments, such as those based on the diagnostic statistical manual. A transcultural and historical perspective is employed to identify relevant symptoms of mood disorders and their temporal course. Descriptions and definitions of classical symptoms are provided and extended based on modern evidence to include changes in self-imagery, moral emotions, self-blame-related action tendencies, as well as mood-congruent biases in the representation of the past and future. Lastly the contribution of psychopathology to future subsyndrome discovery, translational cognitive neuroscience, and network-based approaches to the psychopathology of mood disorders is discussed.
During the menopausal transition, women often encounter a range of physical and psychological symptoms which negatively impact on health-related quality of life (HRQoL)(1). Diet quality has previously been identified as a modifiable factor associated with mitigating the severity of these symptoms in peri-menopausal and menopausal women(2). We therefore explored the independent associations between adherence to a Mediterranean diet (MedDiet) and the severity of menopausal symptoms in peri-menopausal and menopausal women living in Australia. We also explored the association between MedDiet adherence and HRQoL in this same cohort of women. We conducted a cross-sectional study of Australian peri-menopausal or menopausal women aged between 40 to 60 years. An 86-item self-administered questionnaire was used to assess the relationship between adherence to a MedDiet and severity of symptoms. MedDiet adherence was assessed using the Mediterranean Diet Adherence Screener (MEDAS), the Menopause Rating Scale (MRS) was used to assess the severity of menopausal symptoms related to somatic, psychological and urinary-genital symptoms and the 36-item short form survey instrument (SF-36) was used to assess HRQoL. Multivariable linear regression analysis (and 95% CI) was used to investigate the independent association between adherence to a MedDiet, severity of menopausal symptoms and HRQoL subscales using one unadjusted and five adjusted predictor models. A total of n = 207 participants (50.7 ± 4.3 years; BMI: 28.0 ± 7.4 kg/m2) were included in the final analyses. Participants reported low-moderate adherence to a MedDiet (5.2 ± 1.8; range: 1-11). We showed that MedDiet adherence was not associated with severity of menopausal symptoms. However, when assessing individual dietary constituents of the MEDAS, we showed that low consumption of sugar-sweetened beverages (<250ml per day) was inversely associated with joint and muscle complaints, independent of all covariates (β = −0.149; CI: −0.118, −0.022; P = 0.042). Furthermore, adherence to a MedDiet was positively associated with the physical function subscale of HRQoL (β = 0.173, CI: 0.001, 0.029; P = 0.031) and a low intake of red and processed meats (≤ 1 serve per day) was positively associated with the general health subscale (β = 0.296, CI: 0.005, 0.014; P = <0.001), independent of all covariates used in the fully adjusted model. Our results suggest that diet quality may be related to severity of menopausal symptoms and HRQoL in peri-menopausal and menopausal women. However, exploration of these findings using longitudinal analyses and robust clinical trials are needed to better elucidate these findings.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to viral gastroenteritis (rotaviruses, noroviruses, caliciviruses, adenoviruses, sapoviruses, astroviruses). It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to Prion disease (CJD, vCJD). It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to rotaviruses. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to human coronaviruses (SARS-CoV, MERS-CoV and SARS-CoV-2. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to Toxoplasma gondii. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to HIV. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to rabies virus. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to HSV. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to human CMV. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to influenza viruses. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter provides details of the viruses associated with malignancies (HBV, HCV, HTLV1, EBV, HPVs, HHV8). It gives details of symptoms, risk factors, treatment and prevention strategies.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to parainfluenzaviruses. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to HAV. It provides information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.
This chapter details the epidemiology, route of spread, prevalence and incubation periods relating to the organisms which cause atypical pneumonia (M.pneumoniae, C.psittaci, C.burnetii, L.pneumophila). It gives information on symptoms, laboratory diagnosis, treatment, and outbreaks.